Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Clinical trial NCT00780598 · COMPLETED
Trial details
- NCT number
- NCT00780598
- Sponsor
- Chroma Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-03-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.